Istituto Oncologico di Bari Giovanni Paolo II

Bari 70124

0 studies enrolling now · 1 studies all time

What they study most

Advanced Malignancies, Carcinoma, Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants — Completed